Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Health & wellness /
      By the numbers: Helping to reduce disparities in cancer care
      A close-up of two people holding hands

      By the numbers: Helping to reduce disparities in cancer care

      For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.

      Share Article
      share to

      It’s no surprise that cancer remains an urgent healthcare priority around the world. What may be surprising for some to learn is how the disease particularly impacts people of color. While cancer deaths among Black people, for example, have declined, this group still experiences the highest cancer death rates of any population group. They’re also less likely to get diagnosed and treated for the leading causes of cancer deaths, such as lung cancer.

      One critical way to reduce cancer health disparities is to make clinical trials more representative of patients. That’s why Johnson & Johnson is collaborating with partners to build and promote the advancement of Diversity, Equity and Inclusion (DEI) in clinical trials and reduce the many barriers preventing equitable trials from happening.

      For World Health Day, we’re taking a look at cancer inequities across the globe and the role Johnson & Johnson is playing.

      An infographic with statistics about reducing disparities in cancer care

      Learn More About Janssen’s Approach to Diversity in Clinical Trials

      See how the company is committed to ensuring that its clinical research studies reflect a wide range of races, ethnicities, ages and lifestyles.

      More from Johnson & Johnson

      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      Innovation
      Headshots of three Johnson and Johnson female scientists

      Meet 3 leaders who are breaking new ground for women in healthcare

      For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.